Status:
TERMINATED
Dysregulated Tyrosine Kinase Signaling in Leukemia
Lead Sponsor:
University of New Mexico
Conditions:
Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Dysregulated Tyrosine Kinase Signaling in Leukemia
Detailed Description
Purpose: to look at a number of proteins in the abnormal cells in the blood and/or bone marrow. These proteins make a cell grow or prevent the cell from dying
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients must have newly diagnosed or relapsed leukemia.
- Patients must sign an informed consent.
- Patients will not be excluded if they are receiving chemotherapy.
- Patients with CML, AML, ALL, T/NK leukemia, myelodysplasia, or myeloproliferative disorders will be eligible.
- Patients must be =\> 18 years of age.
Exclusion
Key Trial Info
Start Date :
May 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00277056
Start Date
May 1 2002
End Date
October 1 2005
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico
Albuquerque, New Mexico, United States, 87131